Literature DB >> 3341434

Twin vessels in von Hippel-Lindau disease.

P T de Jong1, R J Verkaart, M J van de Vooren, D F Majoor-Krakauer, A R Wiegel.   

Abstract

We examined ten patients from three families with von Hippel-Lindau disease and 26 of their at-risk relatives for the presence of twin vessels, defined as a paired retinal arteriole and venule that are separated by less than the diameter of one venule and extend for a distance of more than one disk diameter. They were compared with 36 age- and sex-matched controls. Of the 36 subjects in the study group, 23 had twin vessels compared with two controls (P less than 10(-6). Of the ten patients, nine (14 eyes) had twin vessels; no twin vessels were found in their controls (P = 5.9 x 10(-5)). Fourteen at-risk relatives and two of their controls had twin vessels (P = 9.4 x 10(-4)).

Entities:  

Mesh:

Year:  1988        PMID: 3341434     DOI: 10.1016/0002-9394(88)90181-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

Review 1.  [Retinal angiomatosis. Ocular manifestation of von Hippel-Lindau disease].

Authors:  B Junker; D Schmidt; H T Agostini
Journal:  Ophthalmologe       Date:  2007-02       Impact factor: 1.059

2.  Retinal vascular proliferation as an ocular manifestation of von Hippel-Lindau disease.

Authors:  Wai T Wong; Steven Yeh; Chi-Chao Chan; Robert E Kalina; James L Kinyoun; James C Folk; Hanna R Coleman; Emily Y Chew
Journal:  Arch Ophthalmol       Date:  2008-05

3.  Neovascular glaucoma and the occurrence of twin vessels in congenital arteriovenous communications of the retina.

Authors:  P T De Jong
Journal:  Doc Ophthalmol       Date:  1988 Mar-Apr       Impact factor: 2.379

Review 4.  Von Hippel-Lindau Disease and the Eye.

Authors:  Saeed Karimi; Amir Arabi; Toktam Shahraki; Sare Safi
Journal:  J Ophthalmic Vis Res       Date:  2020-02-02

Review 5.  The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis.

Authors:  Petra Hudler; Mojca Urbancic
Journal:  Genes (Basel)       Date:  2022-02-17       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.